Antimuscarinic therapy in men with bladder outlet obstruction

Abrams P., Kaplan S., De Koning Gans H.J., Millard R., Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction, J Urol, 175, pp. 999-1004, (2006)

Macdiarmid S., Chen A., Tu N., Aquilina J., Peters K., Effects of tamsulosin and extended-release oxybutynin on lower urinary tract symptoms in men, J Urol, 175, SUPPL. 4, pp. 1-554, (2006)

Jacobsen S.J., Jacobson D.J., Girman C.J., Et al., Treatment for benign prostatic hyperplasia among community dwelling Men: The Olmsted County study of urinary symptoms and health status, J Urol, 162, pp. 1301-1306, (1999)

Roehrborn C.G., McConnell J.D., Saltzman B., Et al., Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes, Eur Urol, 42, pp. 1-6, (2002)

Abrams P., Kaplan S., De Koning Gans H.J., Millard R., Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction, J Urol, 175, pp. 999-1004, (2006)

Macdiarmid S., Chen A., Tu N., Aquilina J., Peters K., Effects of tamsulosin and extended-release oxybutynin on lower urinary tract symptoms in men, J Urol, 175, SUPPL. 4, pp. 1-554, (2006)

Jacobsen S.J., Jacobson D.J., Girman C.J., Et al., Treatment for benign prostatic hyperplasia among community dwelling Men: The Olmsted County study of urinary symptoms and health status, J Urol, 162, pp. 1301-1306, (1999)

Roehrborn C.G., McConnell J.D., Saltzman B., Et al., Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes, Eur Urol, 42, pp. 1-6, (2002)